Suchergebnisse - "Jang, Heejoon"

PubPharm (23)

1

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

enthalten in: JAMA internal medicine | 2024

von Jang, H. | Kim, Y. | Lee, D. | +5

2

Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease : a nationwide cohort study

enthalten in: EClinicalMedicine | 2023

von Moon, J. | Jeong, S. | Jang, H. | +2

3

Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Lee, Y. | Koo, B. | Joo, S. | +10

CommentIn: Aliment Pharmacol Ther. 2023 Aug;58(3):372-373. - PMID 37452590

4

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients : A Multicenter, Randomized Study

enthalten in: Journal of Korean medical science | 2023

von Jang, H. | Yu, S. | Lee, H. | +6

5

PNPLA3 genotypes modify the adverse effect of the total energy intake on high-risk nonalcoholic steatohepatitis development

enthalten in: The American journal of clinical nutrition | 2023

von Son, H. | Koo, B. | Joo, S. | +6

6

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

enthalten in: Clinical and molecular hepatology | 2023

von Jang, H. | Kim, W.

CommentOn: Clin Mol Hepatol. 2023 Feb;29(Suppl):S79-S85. - PMID 36517003

7

Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Lee, Y. | Koo, B. | Joo, S. | +9

8

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Jang, H. | Lee, Y. | Lee, J.

9

Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation

enthalten in: Digestive diseases and sciences | 2022

von Park, M. | Lee, Y. | Moon, H. | +9

10

Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Jang, H. | Lee, Y. | Moon, H. | +8

CommentIn: Hepatology. 2022 Aug;76(2):300-302. - PMID 35254662